Lâautofluorescence cutanée est un marqueur prédictif de macroangiopathie dans le diabète de type 1
Christèle Bisson, Vincent Rigalleau(Université de Bordeaux), Cécile Delcourt, Kalina Rajaobelina(Université de Bordeaux), Catherine Helmer(Inserm), Marie Monlun(Hôpital Cardiologique du Haut-Lévêque), Audrey Cougnard‐Grégoire(University of Manchester), Laure Alexandre(Centre Hospitalier Universitaire de Bordeaux), Laurence Blanco(Hôpital Cardiologique du Haut-Lévêque), Fl Velayoudom-Cephise, Kamel Mohammedi(Hôpital Cardiologique du Haut-Lévêque)
Unknown
February 16, 2018
Cited by 0
Related Papers
The changing prevalence and incidence of dementia over time — current evidence
|Nature Reviews Neurology|2017|773
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease
|JAMA Internal Medicine|2016|405
Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality
|Circulation|2019|335
Trial of Lixisenatide in Early Parkinson’s Disease
|New England Journal of Medicine|2024|302
Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies
|Nature Communications|2021|241